MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features"

  • MDS Virtual Congress 2021

    Validation of smartphone-based active tests with structural neuroimaging in Huntington’s disease

    J. Rennig, S. Holiga, D. Hawellek, F. Lipsmeier, J. Dorn, S. Schobel, C. Simillion, M. Lindemann (Basel, Switzerland)

    Objective: Explore the association of smartphone-based active tests in the Roche Huntington’s disease (HD) Digital Monitoring Platform (dMP) with brain imaging. Background: Remote digital monitoring…
  • MDS Virtual Congress 2021

    Comparison of correlations of structural magnetic resonance imaging measures with smartphone-based active tests and clinical tests in Huntington’s disease

    J. Rennig, D. Hawellek, J. Dorn, F. Lipsmeier, S. Holiga, C. Simillion, S. Schobel, M. Lindemann (Basel, Switzerland)

    Objective: The current study aims to explore the similarities and differences between neuronal correlates of established clinical or novel Roche Huntington’s disease (HD) Digital Monitoring…
  • MDS Virtual Congress 2021

    Post-infectious Anti-GFAP-associated meningoencephalitis: A case report

    T. Ahn, J. Joo (Seoul, Republic of Korea)

    Objective: To report a clinical manifestation of severe choreoballistic movement in a patient with anti-glial fibrillary acidic protein (GFAP) antibody positive autoimmune encephalitis Background: GFAP…
  • MDS Virtual Congress 2021

    Using patient-reported quality of life outcomes to assess the validity of smartphone-based remote assessment of motor and cognitive performance in manifest Huntington’s disease patients

    F. Riese, J. Rennig, F. Lipsmeier, A. Bamdadian, S. Schobel, C. Gossens, P. Weydt, J. Dorn, E. Wild, D. Trundell, C. Simillion, M. Lindemann (Basel, Switzerland)

    Objective: Explore associations between remote monitoring of cognitive and motor functions and digitally administered, self-assessed EuroQol 5-dimension 5-level (EQ-5D-5L) items. Background: Assessment of cognitive and…
  • MDS Virtual Congress 2020

    Clinical and etiological aspects of movement disorders in a low-income country: Case of Mali

    A. Bocoum, S.H Diallo, S. Diallo, A. Koita, Y. Maiga (Bamako, Mali)

    Objective: Describing Clinical and etiological aspects of movement disorders in Mali Background: Movement disorders (MD) correspond to a disturbance in the programming and / or…
  • MDS Virtual Congress 2020

    Development of a time-to-event endpoint for use in premanifest Huntington’s disease (HD) clinical trials

    S. Rossomanno, H. Guthrie, E.J Wild, S.A Schobel, L. Boak, D. Trundell (Basel, Switzerland)

    Objective: To develop and evaluate a time-to-event endpoint to measure disease progression in individuals with premanifest HD. Background: HD is typically diagnosed between the ages…
  • MDS Virtual Congress 2020

    Implementation of an online, interactive curriculum in movement disorders at nine neurology residency programs

    S. Schaefer, Z. London, J. Ferrara, M. McCoyd, C. Cronin, E. Poole Pharr, R. Price, M. Cincotta, H. Rigby, S. Vota, M. Slade, J. Moeller (New Haven, CT, USA)

    Objective: Determine knowledge growth and resident satisfaction with an online curriculum in movement disorders across multiple programs. Background: Exposure to movement disorders in residency is…
  • MDS Virtual Congress 2020

    How Well Does the Composite Unified Huntington’s Disease Rating Scale (cUHDRS) Reflect Disease Progression in Huntington’s disease (HD)?

    C. Snell, H. Smith, J. Castleton, A. Hall, A. Smirnova, B. Wright, P. Gilbert, J. Corey-Bloom (La Jolla, CA, USA)

    Objective: To examine the usefulness of the cUHDRS in reflecting disease progression in a well-characterized group of mild to moderate HD subjects followed at one…
  • MDS Virtual Congress 2020

    Sleep and Polysomnographic Abnormalities in Indian Patients with Huntington’s Disease

    J. Annapureddy, S. D V, N. Kamble, P. Pal, S. Jain, B. Kutty, R. Yadav (Bangalore, India)

    Objective: To study the sleep abnormalities in patients with HD by usingquestionnaire and Video Polysomnography (VPSG) and correlate with the eye movement abnormalities. Background: About 87.8% of the patients report some sleep disturbance…
  • MDS Virtual Congress 2020

    Speech is a sensitive marker in premanifest Huntington’s disease: exploring acoustic, cognitive and fine motor performance

    A. Vogel, J. Chan, Y. Lie, J. Stout (Melbourne, Australia)

    Objective: To explore the utility of objective analysis of speech as a quantifiable clinical biomarker in premanifest HD. Background: The autosomal dominant inheritance of Huntington’s…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley